EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism

Ling-Yu Tian, Daniel J Smit iD, Manfred Jücker iD

International Journal of Molecular Sciences · 31.01.2023 · 24 (3) · 2652

DOI: 10.3390/ijms24032652 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.01.2023. Verfasst von Ling-Yu Tian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry and Signal Transduction, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 337-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in the world. Metabolic reprogramming is considered a new hallmark of cancer, but it remains unclearly described in HCC. The dysregulation of the PI3K/AKT/mTOR signaling pathway is common in HCC and is, therefore, a topic of further research and the concern of developing a novel target for liver cancer therapy. In this review, we illustrate mechanisms by which this signaling network is accountable for regulating HCC cellular metabolism, including glucose metabolism, lipid metabolism, amino acid metabolism, pyrimidine metabolism, and oxidative metabolism, and summarize the ongoing clinical trials based on the inhibition of the PI3K/AKT/mTOR pathway in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesCell Line, TumorSignal TransductionTOR Serine-Threonine Kinases

Stichwörter der Autor:innen

HCC treatmentamino acid metabolismcancer therapyglucose metabolismlipid metabolismoxidative metabolismpyrimidine metabolismtumor microenvironment

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesMTOR protein, human

Autor:innen und Institutionen

  • Institute of Biochemistry and Signal Transduction, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

ORCID-Profile: Daniel J Smit, Manfred Jücker

Förderung

  • China Scholarship Council

Zitieren

APA

Tian, L. Y., Smit, D. J., & Jücker, M. (2023). The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism. International Journal of Molecular Sciences, 24(3), 2652. https://doi.org/10.3390/ijms24032652

Vancouver

Tian LY, Smit DJ, Jücker M. The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism. International Journal of Molecular Sciences. 2023;24(3):2652. doi:10.3390/ijms24032652

BibTeX
@article{Tian2023,
  author = {Tian, Ling-Yu and Smit, Daniel J and Jücker, Manfred},
  title = {The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {3},
  pages = {2652},
  doi = {10.3390/ijms24032652}
}
Kostenlos starten →